Jin Sung Kim

Jin Sung Kim

Auto-generated profile, based on publicly available information

Jin Sung Kim

Department of Surgery, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 May 2021 in Vascular Specialist International
Verified
Journal Article
Open access
PDF file
SGSangmin Gong
Sangmin Gong
ELEun Ji Lee
Eun Ji Lee
JKJin Sung Kim
Jin Sung Kim
HKHyangkyoung Kim
Hyangkyoung Kim
MNMinsu Noh
Minsu Noh
SPSang Jun Park
Sang Jun Park
Sangmin Gong, Eun Ji Lee, Jin Sung Kim, Hyangkyoung Kim, Minsu Noh, Hojong Park, Bong Won Park, Songsoo Yang, and Sang Jun Park. Vasc Specialist Int 2021;37:. https://doi.org/10.5758/vsi.200075

1 January 2019 in Journal of Gastric Cancer
Verified
Journal Article
Open access
PDF file
JKJin Sung Kim
Jin Sung Kim
EPEun Young Park
Eun Young Park
DPDong Jin Park
Dong Jin Park
GKGyu Yeol Kim
Gyu Yeol Kim
Kim JS, et al. J Gastric Cancer. 2019 Apr;19:e30. https://doi.org/10.5230/jgc.2019.19.e30

5 March 2025 in BMC Surgery
Verified
Journal Article
Open access
PDF file
JKJinAh Kwon
JinAh Kwon
JBJung Hee Byon
Jung Hee Byon
BKByung Kyun Ko
Byung Kyun Ko
JKJin Sung Kim
Jin Sung Kim
MBMinseo Bang
Minseo Bang
The cosmetic outcomes of breast-conserving surgery (BCS) have recently gained increasing attention, and surgeons are exploring the use of the acellular dermal matrix (ADM) as a safe and effective method of breast reconstruction. This study evaluated the clinical progress of patients with breast cancer following the application of sheet-type ADM for breast reconstruction after BCS. This retrospective study included 137 patients who underwent BCS using ADM at a single center between October 2019 and October 2021. During surgery, sheet-type ADM was folded and inserted into the excised defects. Complications and cancer recurrence were evaluated during surveillance follow-up until December 2023, and maintenance of the inserted ADM was quantitatively compared using volume analysis of the first and last follow-up computed tomography (CT). Of the 137 evaluated patients, 16 (11.6%) had minor complications, and 17 (12.4%) underwent biopsy during the surveillance period. One patient was diagnosed with recurrence. ADM volume was measured in 55 patients. The mean volume reduction between the first and last CT scans was 1.81 ± 2.06 cm³ (a decrease of 17.42 ± 19.82%), which was statistically significant (p < 0.001). The insertion of ADM after BCS is a safe and effective method for addressing volume defects, even though a slight reduction occurs in ADM volume.

1 January 2021 in Annals of Surgical Treatment and Research
Verified
Journal Article
Open access
PDF file
JKJin Sung Kim
Jin Sung Kim
KBKyoungkyg Bae
Kyoungkyg Bae
ELEun Ji Lee
Eun Ji Lee
MBMinseo Bang
Minseo Bang
Kim JS, et al. Ann Surg Treat Res. 2021 Jun;100(6):313-319. https://doi.org/10.4174/astr.2021.100.6.313

15 October 2024 in Cancer Research and Treatment
Verified
Journal Article
Open access
PDF file
JKJin Ah Kwon
Jin Ah Kwon
SYSongsoo Yang
Songsoo Yang
SKSu-Jin Koh
Su-Jin Koh
YNYoung Ju Noh
Young Ju Noh
DKDong Yoon Kang
Dong Yoon Kang
MOMinsu Ock
Minsu Ock
Purpose A “Smart Cancer Care” platform that integrates patient-reported outcomes (PROs) with management has been established in Korea. This study focused on improving health behaviors and connecting patients to welfare services by introducing and assessing the feasibility of “Smart Cancer Care 2.0,” an enhanced version designed for monitoring complications post-cancer treatment.Materials and Methods Smart Cancer Care 2.0 was developed by conducting a literature review and consulting with expert panels to identify symptoms or variables requiring monitoring and management guidelines based on the treatment type. Qualitative and quantitative surveys were conducted to assess the feasibility of the app and web system based on the experiences of patients with cancer and healthcare workers.Results A total of 81 symptoms or variables (chemotherapy-, surgery-, radiotherapy-, rehabilitation-, and health management-related) were selected for management in Smart Cancer Care 2.0. PROs for these symptoms were basically categorized into three severity grades: preventive management, self-treatment, and consultation with a healthcare worker or visit to a healthcare institution. The overall mean scores in the feasibility evaluation by patients and healthcare workers were 3.83 and 3.90 points, respectively, indicating high usefulness.Conclusion Smart Cancer Care 2.0 leverages the existing information and communication technologies–based platform, Smart Cancer Care, and further includes health behaviors and welfare services. Smart Cancer Care 2.0 may play a crucial role in establishing a comprehensive post-discharge management system for patients with cancer as it provides suitable interventions based on patients’ responses and allows the regularly collected PROs to be easily viewed for streamlined care.

1 January 2025 in Annals of Surgical Treatment and Research
Verified
Journal Article
Open access
PDF file
JKJin Ah Kwon
Jin Ah Kwon
JKJin Sung Kim
Jin Sung Kim
IPIn Kyu Park
In Kyu Park
SYSongsoo Yang
Songsoo Yang
DPDong Jin Park
Dong Jin Park
GKGyu Yeol Kim
Gyu Yeol Kim
Kwon JA, et al. Ann Surg Treat Res. 2025 Nov;109(5):310-317. https://doi.org/10.4174/astr.2025.109.5.310